Skip to main content
SpringerLink
Log in

Cardiomiopatie

  • Chapter
Risonanza magnetica cardiaca

  • 730 Accesses

Riassunto

Le cardiomiopatie (CMP) costituiscono un eterogeneo gruppo di patologie associate a disfunzione cardiaca, secondo la definizione fornita dalla Task Force della WHO-ISFC nel 1995 [1]. Le cardiomiopatie sono state classificate in: dilatativa (CMD), ipertrofica (CMI), restrittiva (CMR), aritmogena del ventricolo destro (MAVD), nel gruppo delle cardiomiopatie specifiche (CMS); infine, il gruppo delle cardiomiopatie non classificabili include i casi che non rientrano negli altri gruppi, e che quindi sono stati esclusi dalla classificazione stessa (Tabella 10.1) [1].

Classificazione delle cardiomiopatie secondo la Task Force della WHO-ISFC

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliografia

  1. Richardson PJ, McKenna W, Bristow M et al (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93(5):841–842

    CAS  PubMed  Google Scholar 

  2. Kronik G, Slany J, Mosslacher H (1979) Comparative value of eight M-mode echocardiographic formulas for determining left ventricular stroke volume. Circulation 60:1308–1316

    CAS  PubMed  Google Scholar 

  3. Pons-Llado G, Carreras F, Borras X et al (1997) Comparison of morphologic assessment of hypertrophic cardiomyopathy by magnetic resonance versus echocardiographic imaging. Am J Cardiol 79(12):1651–1656

    Article  CAS  PubMed  Google Scholar 

  4. Earls JP, Ho VB, Foo TK et al (2002) Cardiac MRI: recent progress and continued challenges. J Magn Reson Imaging 16:111–127

    Article  PubMed  Google Scholar 

  5. Pennell DJ, Sechtem UP, Higgins CB et al (2004) Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J 25:1940–1965

    Article  PubMed  Google Scholar 

  6. Villuendas R, Kadish AH (2008) Cardiac Magnetic Resonance for risk stratification: the sudden death risk portrayed. Prog Cardiovasc Dis 51(2):128–134

    Article  PubMed  Google Scholar 

  7. Roberts WC, Siegel RJ, McManus BM (1987) Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol 60:1340–1355

    Article  CAS  PubMed  Google Scholar 

  8. Juilliere Y, Danchin N, Briancon S et al (1988) Dilated cardiomyopathy: long-term follow-up and predictors of survival. Int J Cardiol 21:269–277

    Article  CAS  PubMed  Google Scholar 

  9. Richardson PJ, Why HJF, Archard LC (1992) Virus infection and dilated cardiomyopathy. Postgrad Med J 68[Suppl 1]:S17–S20

    PubMed  Google Scholar 

  10. Pauschinger M, Bowles NE, Fuentes-Garcia FJ et al (1999) Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 99:1348–1354

    CAS  PubMed  Google Scholar 

  11. Caforio ALP, Mahon NJ, Tona F, McKenna WJ (2002) Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur J Heart Fail 4:411–417

    Article  PubMed  Google Scholar 

  12. McCrohon JA, Moon JCC, Prasad SK et al (2003) Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108:54–59

    Article  CAS  PubMed  Google Scholar 

  13. De Cobelli F, Pieroni M, Esposito A et al (2006) Delayed gadolinium-enhanced cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias. J Am Coll Cardiol 47(8):1649–1654

    Article  PubMed  Google Scholar 

  14. Assomull RG, Prasad SK, Lyne J et al (2006) Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48(10):1977–1985

    Article  PubMed  Google Scholar 

  15. Basso C, Thiene G, Corrado D et al (2000) Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Hum Pathol 31(8):988–998

    Article  CAS  PubMed  Google Scholar 

  16. Schoen FJ (1999) Cuore. In: Cotran RS, Kumar V, Collins T (eds) Robbins — Le basi patologiche delle malattie. W.B. Saunders Company, Philadelphia, pp 635–703

    Google Scholar 

  17. Maron MS, Olivotto I, Batocchi S et al (2003) Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 38(4):295–303

    Article  Google Scholar 

  18. Choudhury L, Mahrholdt H, Wagner A et al (2002) Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40(12):2156–2164

    Article  PubMed  Google Scholar 

  19. Maron BJ, Olivotto I, Spirito P et al (2000) Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation 102:858–864

    CAS  PubMed  Google Scholar 

  20. Olivotto I, Maron MS, Autore C et al (2008) Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 52(7):559–566

    Article  PubMed  Google Scholar 

  21. Moon JC, Reed E, Sheppard MN et al (2004) The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 43(12):2260–2264

    Article  PubMed  Google Scholar 

  22. Moon JCC, McKenna WJ, McCrohon JA et al (2003) Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41(9):1561–1567

    Article  PubMed  Google Scholar 

  23. Adabag AS, Maron BJ, Appelbaum E et al (2008) Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relataion to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 51:1369–1374

    Article  PubMed  Google Scholar 

  24. Rudolph A, Abdel-Aty H, Bohl S et al (2009) Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy. J Am Coll Cardiol 53(3):284–291

    Article  PubMed  Google Scholar 

  25. van Dockum WG, ten Cate FJ, ten Berg JM et al (2004) Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol 43(1):27–34

    Article  PubMed  Google Scholar 

  26. Abelmann WH (1984) Classification and natural history of primary myocardial disease. Prog Cardiovasc Dis 27:73–94

    Article  CAS  PubMed  Google Scholar 

  27. Shehata ML, Turkbey EB, Vogel-Claussen J, Bluemke DA (2008) Role of cardiac magnetic resonance imaging in assessment of nonischemic cardiomyopathies. Top Magn Reson Imaging 19(1):43–57

    Article  PubMed  Google Scholar 

  28. Kushwaha SS, Fallon JT, Fuster V (1997) Restrictive cardiomyopathy. N Engl J Med 336(4):267–276

    Article  CAS  PubMed  Google Scholar 

  29. Esposito A, De Cobelli F, Belloni E et al (2009) Magnetic resonance imaging of a hypereosinophilic endocarditis with apical thrombotic obliteration in Churg-Strauss syndrome complicated with acute abdominal aortic embolic occlusion. Int J Cardiol 21 [Epub ahead of print]

    Google Scholar 

  30. Talreja DR, Edwards WD, Danielson GK et al (2003) Constrictive pericarditis in 26 patients with histologically normal pericardial thickness. Circulation 108(15):1852–1857

    Article  PubMed  Google Scholar 

  31. Francone M, Dymarkowski S, Kalantzi M, Bogaert J (2005) Real-time cine MRI of ventricular septal motion. A novel approach to assess ventricular coupling. J Magn Reson Imaging 234:542–547

    Google Scholar 

  32. Maceira AM, Joshi J, Prasad SK et al (2005) Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111:186–193

    Article  PubMed  Google Scholar 

  33. Arbustini E, Gavazzi A, Merlini G (2002) Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know. Ital Heart J [Suppl 3]:590–597

    Google Scholar 

  34. Maceira AM, Prasad SK, Hawkins PN et al (2008) Cardiovascular magnetic resonance and prognosis in amyloidosis. J Cardiovasc Magn Reson 10:54

    Article  PubMed  Google Scholar 

  35. Vogelsberg H, Mahrholdt H, Deluigi CC et al (2008) Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis. J Am Coll Cardiol 51(10):1022–1030

    Article  PubMed  Google Scholar 

  36. Ruberg FL, Appelbaum E, Davidoff R et al (2009) Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. Am J Cardiol 103:544–549

    Article  PubMed  Google Scholar 

  37. Perugini E, Rapezzi C, Piva T et al (2006) Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart 92:343–349

    Article  CAS  PubMed  Google Scholar 

  38. Matsui Y, Iway K, Tachibana T et al (1976) Clinico-pathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci 278:455–469

    Article  CAS  PubMed  Google Scholar 

  39. Sharma OP (1997) Cardiac and neurologic dysfunction in sarcoidosis. Clin Chest Med 18:813–825

    Article  CAS  PubMed  Google Scholar 

  40. Vignaux O, Dhote R, Duboc D et al (2002) Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest 122:1895–1901

    Article  PubMed  Google Scholar 

  41. Smedema JP, Snoep G, van Kroonenburgh MPG et al (2005) Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 45(10):1683–1690

    Article  PubMed  Google Scholar 

  42. Vignaux O (2005) Cardiac sarcoidosis: spectrum of mri features. Am J Roentgenol 184:249–254

    Google Scholar 

  43. Tadamura E, Yamamuro M, Kubo S et al (2005) Effectiveness of delayed enhanced mri for identification of cardiac sarcoidosis: comparison with radionuclide imaging. Am J Roentgenol 185:110–115

    Google Scholar 

  44. Ichinose A, Otani H, Oikawa M et al (2008) MRI of cardiac sarcoidosis: basal and subepicardial localization of myocardial lesions and their effect on left ventricular function. Am J Roentgenol 191:862–869

    Article  Google Scholar 

  45. Matoh F, Satoh H, Shiraki K et al (2008) The usefulness of delayed enhancement magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients in cardiac sarcoidosis. J Cardiol 51:179–188

    Article  PubMed  Google Scholar 

  46. Moon JCC, Sachdev B, Elkington AG et al (2003) Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Eur Heart J 24:2151–2155

    Article  PubMed  Google Scholar 

  47. Moon JC, Sheppard M, Reed E et al (2006) The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease. J Cardiovasc Magn Reson 8:479–482

    Article  PubMed  Google Scholar 

  48. De Cobelli F, Esposito A, Belloni E et al (2009) Delayedenhanced cardiac mri for differentiation of Fabry’s disease from symmetric hypertrophic cardiomyopathy. Am J Roentgenol 192:97–102

    Article  Google Scholar 

  49. Desnick RJ, Brady R, Barranger J et al (2003) Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 138:338–346

    PubMed  Google Scholar 

  50. Pierre-Louis B, Kumar A, Frishman WH (2009) Fabry disease: cardiac manifestations and therapeutic options.Cardiol Rev 17(1):31–35

    Article  PubMed  Google Scholar 

  51. Anderson LJ, Holden S, Davies B et al (2001) Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22:2171–2179

    Article  CAS  PubMed  Google Scholar 

  52. Ramazzotti A, Pepe A, Positano V et al (2009) Multicenter validation of the magnetic resonance T2* technique for segmental and global quantification of myocardial iron. J Magn Reson Imaging 30(1):62–68

    Article  PubMed  Google Scholar 

  53. Mavrogeni SI, Markussis V, Kaklamanis L et al (2005) A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with beta-thalassemia major. Eur J Haematol 75:241–247

    Article  CAS  PubMed  Google Scholar 

  54. Belloni E, De Cobelli F, Esposito A et al (2008) MRI of cardiomyopathy. Am J Roentgenol 191:1702–1710

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento di Radiologia, IRCCS Ospedale San Raffaele, Università Vita-Salute San Raffaele, Milano

    Francesco De Cobelli, Elena Belloni, Antonio Esposito & Alessandro Del Maschio

Authors
  1. Francesco De Cobelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elena Belloni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antonio Esposito
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alessandro Del Maschio
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Italia

About this chapter

Cite this chapter

De Cobelli, F., Belloni, E., Esposito, A., Del Maschio, A. (2010). Cardiomiopatie. In: Risonanza magnetica cardiaca. Springer, Milano. https://doi.org/10.1007/978-88-470-1694-1_11

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-1694-1_11

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-1693-4

  • Online ISBN: 978-88-470-1694-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation